171 related articles for article (PubMed ID: 17368038)
1. ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance.
de Jonge-Peeters SD; Kuipers F; de Vries EG; Vellenga E
Crit Rev Oncol Hematol; 2007 Jun; 62(3):214-26. PubMed ID: 17368038
[TBL] [Abstract][Full Text] [Related]
2. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
Ho MM; Hogge DE; Ling V
Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
[TBL] [Abstract][Full Text] [Related]
3. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
[TBL] [Abstract][Full Text] [Related]
4. Leukemia and ABC transporters.
Fukuda Y; Lian S; Schuetz JD
Adv Cancer Res; 2015; 125():171-96. PubMed ID: 25640270
[TBL] [Abstract][Full Text] [Related]
5. Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells.
Peeters SD; van der Kolk DM; de Haan G; Bystrykh L; Kuipers F; de Vries EG; Vellenga E
Exp Hematol; 2006 May; 34(5):622-30. PubMed ID: 16647568
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.
Raaijmakers MH; de Grouw EP; Heuver LH; van der Reijden BA; Jansen JH; Scheper RJ; Scheffer GL; de Witte TJ; Raymakers RA
Clin Cancer Res; 2005 Mar; 11(6):2436-44. PubMed ID: 15788695
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
[TBL] [Abstract][Full Text] [Related]
8. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
[TBL] [Abstract][Full Text] [Related]
9. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.
Raaijmakers MH
Leukemia; 2007 Oct; 21(10):2094-102. PubMed ID: 17657220
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
[TBL] [Abstract][Full Text] [Related]
11. ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport.
Wulf GG; Modlich S; Inagaki N; Reinhardt D; Schroers R; Griesinger F; Trümper L
Haematologica; 2004 Nov; 89(11):1395-7. PubMed ID: 15531465
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.
Bartholomae S; Gruhn B; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Steinbach D
Pediatr Blood Cancer; 2016 Feb; 63(2):242-7. PubMed ID: 26512967
[TBL] [Abstract][Full Text] [Related]
13. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.
van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P
Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes.
Hauswald S; Duque-Afonso J; Wagner MM; Schertl FM; Lübbert M; Peschel C; Keller U; Licht T
Clin Cancer Res; 2009 Jun; 15(11):3705-15. PubMed ID: 19458058
[TBL] [Abstract][Full Text] [Related]
15. ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine.
Mehrvar N; Akbari ME; Rezvany MR; Abolghasemi H; Saberynejad J; Mehrvar A; Faranoush M; Keramatinia AA; Shekarriz-Foumani R; Movafagh A
Cell Mol Biol (Noisy-le-grand); 2019 Feb; 65(2):7-13. PubMed ID: 30860475
[TBL] [Abstract][Full Text] [Related]
16. Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?
Steinbach D; Friedrich J; Dawczynski K; Furchtbar S; Gruhn B; Wittig S; Zintl F; Sauerbrey A
Leuk Lymphoma; 2005 Sep; 46(9):1357-63. PubMed ID: 16109615
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells.
Tang L; Bergevoet SM; Gilissen C; de Witte T; Jansen JH; van der Reijden BA; Raymakers RA
BMC Pharmacol; 2010 Sep; 10():12. PubMed ID: 20836839
[TBL] [Abstract][Full Text] [Related]
18. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia.
Steinbach D; Sell W; Voigt A; Hermann J; Zintl F; Sauerbrey A
Leukemia; 2002 Aug; 16(8):1443-7. PubMed ID: 12145683
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O
Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]